Development of a Screening Tool for Pediatric Neuropathic Pain and Complex Regional Pain Syndrome: Pediatric PainSCAN.


Journal

The Clinical journal of pain
ISSN: 1536-5409
Titre abrégé: Clin J Pain
Pays: United States
ID NLM: 8507389

Informations de publication

Date de publication:
12 10 2021
Historique:
received: 02 06 2021
accepted: 29 09 2021
pubmed: 13 10 2021
medline: 3 2 2022
entrez: 12 10 2021
Statut: epublish

Résumé

Neuropathic pain (NP) and complex regional pain syndrome (CRPS) in children can result in significant disability and emotional distress. Early assessment and treatment could potentially improve pain, function, quality of life, and reduce costs to the health care system. Currently, there are no screening tools for pediatric NP and CRPS. This research aimed to develop and establish the content validity of a screening tool for pediatric NP and CRPS using a phased approach. Phase I surveyed clinical experts using a modified Delphi procedure to elicit disease concepts for inclusion. In phase II, a consensus conference including clinicians, researchers, and people with lived experience, informed the initial item pool. Consensus for item inclusion was achieved using a nominal group technique for voting. Phase III used iterative rounds of cognitive interviews with children aged 8 to 18 years with CRPS or NP to evaluate the tool's comprehensiveness and individual item relevance and comprehensibility. Descriptive statistics were used to describe participant characteristics. Content analysis was used to analyze patient interviews. Phase I (n=50) generated an initial item pool (22 items). Phase II generated a comprehensive item pool (50 items), after which an initial version of the screening tool was drafted. Following phase III (n=26) after item revision and elimination, 37 items remained. The Pediatric PainSCAN is a novel screening tool that has undergone rigorous development and content validity testing. Further research is needed to conduct item reduction, determine scoring, and test additional measurement properties.

Identifiants

pubmed: 34636750
doi: 10.1097/AJP.0000000000000993
pii: 00002508-202201000-00003
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15-22

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The consensus conference was funded by a CIHR Planning and Dissemination Grant (Grant #PCS-155274), Canada. G.M. was supported by a Frederick Banting and Charles Best Canada Graduate Scholarship (CGS-M) from the Canadian Institutes of Health Research (CIHR), Canada and a RESTRACOMP Clinician Scientist Training Program Scholarship from the Hospital for Sick Children, Toronto, Canada. The authors declare no conflict of interest.

Références

Scholz J, Finnerup NB, Attal N, et al. The IASP Classification of Chronic Pain for ICD-11: chronic neuropathic pain. Pain. 2019;160:53–59.
Nicholas M, Vlaeyen JWS, Rief W, et al. The IASP Classification of Chronic Pain for ICD-11: chronic primary pain. Pain. 2019;160:28–37.
Torrance N, Smith BH, Bennett MI, et al. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain. 2006;7:281–289.
Freynhagen R, Baron R, Gockel U, et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22:1911–1920.
Attal N, Lanteri-Minet M, Laurent B, et al. The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain. 2011;152:2836–2843.
Morgan KJ, Anghelescu DL. A review of adult and pediatric neuropathic pain assessment tools. Clin J Pain. 2017;33:844–852.
Walker SM. Neuropathic pain in children: steps towards improved recognition and management. EBioMedicine. 2020;62:103124.
Mesaroli G, Ruskin D, Campbell F, et al. clinical features of pediatric complex regional pain syndrome: a 5-year retrospective chart review. Clin J Pain. 2019;35:933–940.
Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14:162–173.
Kimura Y, Walco GA. Treatment of chronic pain in pediatric rheumatic disease. Nat Clin Pract Rheumatol. 2007;3:210–218.
Fletcher RH, Fletcher SW, Fletcher GS. Clinical Epidemiology: The Essentials, 5th ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins Health; 2014.
Walco GA, Dworkin RH, Krane EJ, et al. Neuropathic pain in children: special considerations. Mayo Clin Proc. 2010;85(suppl):S33–S41.
Howard RF, Wiener S, Walker SM. Neuropathic pain in children. Arch Dis Child. 2014;99:84–89.
Stinson J, Birnie KA, Lalloo C, et al. Developing a screening measure for pediatric neuropathic pain. Poster presentation presented at the: Canadian Pain Society Annual Scientific Meeting; 2017.
Mesaroli G, Hundert A, Birnie KA, et al. Screening and diagnostic tools for complex regional pain syndrome: a systematic review. Pain. 2021;162:1295–1304.
Finnerup NB, Haroutounian S, Kamerman P, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain. 2016;157:1599–1606.
Yeung K-K, Engle L, Rabel A, et al. It just feels weird!: a qualitative study of how children aged 10-18 years describe neuropathic pain. Disabil Rehabil. 2017;39:1695–1702.
Terwee CB, Prinsen CaC, Chiarotto A, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018;27:1159–1170.
Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63:737–745.
Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine which outcomes to measure in clinical trials: recommendations for the future based on a systematic review of existing studies. PLoS Med. 2011;8:e1000393.
Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;32:1008–1015.
Sackman H. Delphi Assessment; 1974. Available at: www.rand.org/pubs/reports/R1283.html . Accessed February 27, 2019.
Nekolaichuk CL, Fainsinger RL, Lawlor PG. A validation study of a pain classification system for advanced cancer patients using content experts: the Edmonton Classification System for Cancer Pain. Palliat Med. 2005;19:466–476.
Powell C. The Delphi technique: myths and realities. J Adv Nurs. 2003;41:376–382.
Cook C, Brismée J-M, Sizer PS. Subjective and objective descriptors of clinical lumbar spine instability: a Delphi study. Man Ther. 2006;11:11–21.
Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
Horton JN. Nominal group technique. A method of decision-making by committee. Anaesthesia. 1980;35:811–814.
Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000;23:334–340.
Harden RN, Bruehl S, Perez RSGM, et al. Validation of proposed diagnostic criteria (the “Budapest Criteria”) for complex regional pain syndrome. Pain. 2010;150:268–274.
Coombes L, Bristowe K, Ellis-Smith C, et al. Enhancing validity, reliability and participation in self-reported health outcome measurement for children and young people: a systematic review of recall period, response scale format, and administration modality. Qual Life Res. 2021;30:1803–1832.
Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63:1179–1194.
De Vet HCW, Terwee CB, Mokkink LB, et al. Measurement in Medicine: A Practical Guide. Cambridge, England: Cambridge University Press; 2011.
Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29–36.
Bennett M. The LANSS Pain Scale: the Leeds Assessment of Neuropathic Symptoms and Signs. Pain. 2001;92:147–157.
Fishbain DA, Lewis JE, Cutler R, et al. Can the Neuropathic Pain Scale discriminate between non-neuropathic and neuropathic pain? Pain Med. 2008;9:149–160.
Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale. Neurology. 1997;48:332–338.
Gilchrist LS, Tanner L. The pediatric-modified total neuropathy score: a reliable and valid measure of chemotherapy-induced peripheral neuropathy in children with non-CNS cancers. Support Care Cancer. 2013;21:847–856.
Lavoie Smith EM, Li L, Chiang C, et al. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. J Peripher Nerv Syst. 2015;20:37–46.

Auteurs

Giulia Mesaroli (G)

Departments of Rehabilitation.
Department of Physical Therapy.

Fiona Campbell (F)

Anesthesia and Pain Medicine.

Amos Hundert (A)

Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children.

Kathryn A Birnie (KA)

Departments of Anesthesiology, Perioperative, and Pain Medicine.
Community Health Sciences, University of Calgary, Calgary, AB, Canada.

Naiyi Sun (N)

Anesthesia and Pain Medicine.

Kristen M Davidge (KM)

Division of Plastic and Reconstructive Surgery, The Hospital for Sick Children.

Chitra Lalloo (C)

Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children.
Institute for Health Policy, Management, & Evaluation.

Cleo Davies-Chalmers (C)

Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children.

Lauren Harris (L)

Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children.

Jennifer Stinson (J)

Institute for Health Policy, Management, & Evaluation.
Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH